An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Get Your Free Sample Market Report: What Is Driving the Growth of the Inflammatory Bowel Disease Treatment Market? The increasing incidence of Crohn's disease and ulcerative colitis is a key ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...

What Is Driving the Growth of the Inflammatory Bowel Disease Treatment Market? The increasing incidence of Crohn's disease and ulcerative colitis is a key factor driving growth in the inflammatory ...

What Is Driving the Growth of the Inflammatory Bowel Disease Treatment Market? The increasing incidence of Crohn's disease and ulcerative colitis is a key factor driving growth in the inflammatory ...

Inflammatory Bowel Disease Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company’s Inflammatory Bowel Disease Global Market Report 2025 – Market Size, T ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...